Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-Hodgkin's lymphoma
non-Hodgkin's lymphoma
Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA
Yahoo/AP
Thu, 12/1/11 - 12:56 pm
FDA
orphan drugs
Emergent BioSolutions
leukemia
TRU-016
non-Hodgkin's lymphoma
chronic lymphocytic leukemia
Immunogen begins mid-stage testing of experimental cancer compound, triggers $3M payment
Yahoo/AP
Thu, 10/20/11 - 12:45 pm
Immunogen
Sanofi
SAR3419
non-Hodgkin's lymphoma
Cell Therapeutics Efforts Validated
Yahoo/Zacks
Sat, 10/8/11 - 11:43 am
Cell Therapeutics
pixantrone
non-Hodgkin's lymphoma
ImmunoGen advances lymphoma drug candidate
Bizjournals.com
Fri, 09/23/11 - 12:06 pm
Immunogen
IMGN529
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
Good News for Cell Therapeutics
Yahoo/Zacks.com
Thu, 08/25/11 - 12:20 pm
Cell Therapeutics
pixantrone
non-Hodgkin's lymphoma
Europe
Investors Need a Peephole Into FDA Offices
Motley Fool
Thu, 06/16/11 - 11:12 am
investors
FDA
pixantrone
Cell Therapeutics
non-Hodgkin's lymphoma
ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO
Yahoo/BusinessWire
Sat, 06/4/11 - 10:03 am
Immunogen
SAR3419
non-Hodgkin's lymphoma
FDA Sets Meeting Date in Early June to Discuss Re-submission of Pixantrone NDA for Accelerated Approval
Yahoo
Fri, 05/20/11 - 09:47 am
FDA
pixantrone
Cell Therapeutics
non-Hodgkin's lymphoma
Spectrum Pharma: Zevalin Bubble Deflates
TheStreet.com
Wed, 05/4/11 - 12:37 pm
Zevalin
Spectrum Pharmaceuticals
non-Hodgkin's lymphoma
Major FDA Approval Could Pave the Way for These 5 Biotechs
Seeking Alpha
Thu, 03/31/11 - 11:55 am
FDA
rindopepimut
brain cancer
Celldex
Geron
AML
GRNVAC1
blinatumomab
Micromet
non-Hodgkin's lymphoma
acute lymphoblastic leukemia
Oncothyreon
Stimuvax
breast cancer
lung cancer
Allovectin-7
Vical
melanoma
Genentech: positive results from cancer drug study
Yahoo/AP
Mon, 12/6/10 - 11:00 am
Genentech
Rituxan
Roche
Biogen Idec
non-Hodgkin's lymphoma
Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
Sun Herald, MS
Sun, 12/5/10 - 12:16 pm
Portola Pharmaceuticals
non-Hodgkin's lymphoma
chronic lymphocytic leukemia
rheumatoid arthritis
JAK inhibitors
Syk inhibitors
Cell Therapeutics appeals FDA decision on Pixuvir
Yahoo/AP
Sat, 12/4/10 - 12:02 pm
Cell Therapeutics
Pixuvri
non-Hodgkin's lymphoma
Cell Therapeutics to appeal FDA pixantrone decision
Bizjournals.com
Tue, 09/14/10 - 10:21 am
pixantrone
Cell Therapeutics
non-Hodgkin's lymphoma
GlaxoSmithKline and Genmab announce start of ofatumumab Phase III combination study in non-Hodgkin’s lymphoma
PR-USA.net
Sun, 09/12/10 - 11:48 am
non-Hodgkin's lymphoma
atumumab
Trubion shares skyrocket after Emergent deal announced
bizjournals
Sat, 08/14/10 - 12:16 pm
Trubion
Emergent BioSolutions
arthritis
lupus
non-Hodgkin's lymphoma
leukemia
Cell Therapeutics expands EU application for potential cancer drug pixantrone
Yahoo/AP
Tue, 07/6/10 - 08:59 am
Cell Therapeutics
Europe
pixantrone
non-Hodgkin's lymphoma
Data from Combination of REVLIMID® and Rituxan® in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma Presented at ASCO
Yahoo/BusinessWire
Sat, 06/5/10 - 09:59 am
non-Hodgkin's lymphoma
Revlimid
Rituxan
Cellgene
Cell's Pixantrone Denied Approval
Yahoo/Zacks
Sat, 04/10/10 - 11:41 am
Cell Therapeutics
Pixuvri
non-Hodgkin's lymphoma
Roche seeks to broaden use of cancer drug MabThera
Reuters
Mon, 03/22/10 - 09:57 am
Roche
MabThera
Europe
cancer
non-Hodgkin's lymphoma
Pages
« first
‹ previous
1
2
3
4
next ›
last »